Plain Prescription Prices Act

Bill 118 hr 7970, also known as the Plain Prescription Prices Act, is a piece of legislation introduced in the US Congress. The main goal of this bill is to increase transparency in prescription drug pricing by requiring pharmaceutical companies to disclose the list prices of their medications in direct-to-consumer advertisements.

The bill aims to empower consumers to make more informed decisions about their healthcare by providing them with information about the cost of prescription drugs before they make a purchase. By requiring drug companies to include the list price of their medications in advertisements, the Plain Prescription Prices Act seeks to hold pharmaceutical companies accountable for their pricing practices and help reduce the financial burden on patients.

Additionally, the bill includes provisions to ensure that the information provided in these advertisements is clear and easily understandable to the average consumer. This is important in order to prevent confusion and ensure that patients are able to make informed choices about their healthcare. Overall, the Plain Prescription Prices Act is a bipartisan effort to address the issue of rising prescription drug prices and increase transparency in the healthcare industry. If passed, this legislation has the potential to benefit consumers by providing them with the information they need to make cost-effective decisions about their healthcare.